Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 40 of the 43 references it cites were found in a registry or an index, and 3 are not checked yet.

Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer?

Open access

Abstract

Globally, tobacco kills almost 5 million people around the world annually. Seven first-line pharmacotherapies are currently available and recommended by the United States Public Health Service (USPHS) clinical practice guideline for treating tobacco dependence, all of which have been proven to be effective for increasing tobacco abstinence rates when used as monotherapy. However, not all smokers are able to quit with single-drug therapy. Some smokers may benefit from combination therapy that includes the simultaneous use of different nicotine replacement therapies (NRTs) or medications with different mechanisms of action (e.g. NRT and bupropion). Combination therapy with different types of NRT may provide a therapeutic advantage by increasing serum nicotine concentrations, and combination therapy with different drugs may capitalize on synergy obtained from two different mechanisms of action. However, controversy exists regarding this approach. Available data suggests that combination therapy may increase abstinence rates compared with monotherapy. However, the cost effectiveness of this approach has not been clearly demonstrated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2165/11536100-000000000-00000

Cites

40 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Hughes, 2007, Cochrane Database Syst Rev, 1, CD000031

Cited by

See all 53

Metadata

Authors
Ebbert, J. O., Hays, J. T., & Hurt, R. D.
Affiliations
Mayo Clinic (US)
Corresponding author
Ebbert, Jon O.
Venue
Drugs
Published
2010-04
Volume
70
Issue
6
Pages
643-650
ISSN
0012-6667 (ISSN-L)
OpenAlex
W2080075236
Cited by
53
References
40
Citations by year
2025: 1 · 2024: 1 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 4 · 2012: 4
FWCI
0.45
Type
journal article
Language
en
Open access
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Pfizer
  • National Institutes of Health
  • U.S. Public Health Service
  • National Cancer Institute (CA 138417Z, R01CA138417)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
smoking cessation, combination pharmacotherapy, nicotine replacement therapy, bupropion, tobacco dependence, nicotine abstinence, monotherapy, cost-effectiveness, drug synergy
MeSH terms
Animals, Drug Therapy, Combination, Humans, Nicotine, Smoking, Randomized Controlled Trials as Topic, Smoking Cessation, Bupropion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer? https://app.cochat.ai/papers/10.2165/11536100-000000000-00000
The paper
Ebbert, J. O., Hays, J. T., & Hurt, R. D. (2010). Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer? Drugs. https://doi.org/10.2165/11536100-000000000-00000

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.